FdaApplication
BLA 761449
Identifiers
- fda_app_no: BLA761449
Properties
| Property | Value |
|---|---|
| applicant_name | Fresenius Kabi USA, LLC |
| application_type | BLA |
| approval_date | 2025-03-14 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TYENNE | TOCILIZUMAB-AAZG | 162MG/0.9ML | INJECTABLE;SUBCUTANEOUS |
| TYENNE | — | 162MG/0.9ML | Injection |
| TYENNE | — | 162MG/0.9ML | Injection |
3 products